A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression

We report the case of a 72-year-old female never-smoker with stage IV endothelial growth factor receptor (EGFR) mutated lung adenocarcinoma. This patient was started on first line tyrosine kinase inhibitor (TKI) and seemingly developed new bone metastases under this treatment. As there was a remarka...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bondt, Charlotte, Snoeckx, Annemiek, Raskin, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193755/
https://www.ncbi.nlm.nih.gov/pubmed/32377620
http://dx.doi.org/10.5334/jbsr.1907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193755/
https://www.ncbi.nlm.nih.gov/pubmed/32377620
http://dx.doi.org/10.5334/jbsr.1907

Ejemplares similares